Cargando…

Local control and survival after stereotactic body radiation therapy of early-stage lung cancer patients in Slovenia

BACKGROUND: Stereotactic body radiation therapy (SBRT) precisely and non-invasively delivers ablative radiation dose to tumors in early-stage lung cancer patients who are not candidates for surgery or refuse it. The aim of research was to evaluate local control, overall survival (OS), local progress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stanic, Karmen, But-Hadzic, Jasna, Zagar, Jan, Vrankar, Martina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476907/ https://www.ncbi.nlm.nih.gov/pubmed/37494591 http://dx.doi.org/10.2478/raon-2023-0032

Ejemplares similares

Consolidation Radiotherapy for Patients with Extended Disease Small Cell Lung Cancer in a Single Tertiary Institution: Impact of Dose and Perspectives in the Era of Immunotherapy
por: Stanic, Karmen, et al.
Publicado: (2020)

Long-term Survival of Locally Advanced Stage III Non-small Cell Lung Cancer Patients Treated with Chemoradiotherapy and Perspectives for The Treatment with Immunotherapy
por: Vrankar, Martina, et al.
Publicado: (2018)

Clinical Outcomes in Stage III Non-small Cell Lung Cancer Patients Treated with Durvalumab After Sequential Or Concurrent Platinum-based Chemoradiotherapy – Single Institute Experience
por: Vrankar, Martina, et al.
Publicado: (2021)

Prognostic value of PD-L1 expression in patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy
por: Vrankar, Martina, et al.
Publicado: (2020)

Incorporation of EGFR Mutation Status into M Descriptor of New TNM Classification Influences Survival Curves in Non-small Cell Lung Cancer Patients
por: Stanic, Karmen, et al.
Publicado: (2019)

Intercalated chemotherapy and erlotinib for advanced NSCLC: high proportion of complete remissions and prolonged progression-free survival among patients with EGFR activating mutations
por: Zwitter, Matjaz, et al.
Publicado: (2014)

Trends in Population-based Cancer Survival in Slovenia
por: Zadnik, Vesna, et al.
Publicado: (2021)

The Spine and Carina as a Surrogate for Target Registration in Cone-beam CT Imaging Verification in Locally Advanced Lung Cancer Radiotherapy
por: But-Hadzic, Jasna, et al.
Publicado: (2023)

Impact of Sarcopenia on Survival in Patients With Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy
por: Taylor, James M, et al.
Publicado: (2020)

Treatment Patterns and Real-world Evidence for Stage III Non-small Cell Lung Cancer in Central and Eastern Europe
por: Zemanova, Milada, et al.
Publicado: (2020)

Intercalated chemotherapy and erlotinib for non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations
por: Zwitter, Matjaz, et al.
Publicado: (2016)

Introducing rapid response teams in Slovenia
por: Lokajner, G, et al.
Publicado: (2008)

Stereotactic Body Radiotherapy for Early Stage Lung Cancer
por: Nagata, Yasushi
Publicado: (2013)

Stereotactic body radiation therapy versus fractionated radiation therapy for early-stage bronchopulmonary carcinoid
por: Wegner, Rodney E, et al.
Publicado: (2019)

Adoption of Stereotactic Body Radiotherapy for Stage IA Non–Small Cell Lung Cancer Across the United States
por: Holmes, Jordan A., et al.
Publicado: (2017)

Mucosal melanoma of the head and neck: a population-based study from Slovenia, 1985-2013
por: Plavc, Gaber, et al.
Publicado: (2016)

Angiotensin receptor blockade and stereotactic body radiation therapy for early stage lung cancer ARB & SBRT for early stage lung cancer
por: Maloney, Lauren T., et al.
Publicado: (2022)

Improved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: Population-based survey of 444 patients
por: Kovac, Viljem, et al.
Publicado: (2012)

Prognosis and Risk Factors of Radiation-Induced Lymphopenia in Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy
por: Zhao, Qianqian, et al.
Publicado: (2020)

Stereotactic body radiation therapy mitigates radiation induced lymphopenia in early stage non-small cell lung cancer
por: McLaughlin, Mark F., et al.
Publicado: (2020)

Reduced Margin Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancers
por: Patel, Mayank, et al.
Publicado: (2020)

Clinical Outcomes Following Proton and Photon Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer
por: Bae, Bong Kyung, et al.
Publicado: (2022)

Impact of the Dimensions of Diversity on the Quality of Nursing Care: The Case of Slovenia
por: Starc, Jasmina, et al.
Publicado: (2017)

Association of neutrophil–lymphocyte ratio with survival in peripheral early-stage non-small cell lung cancer after stereotactic body radiation therapy
por: Huang, Karen, et al.
Publicado: (2023)

Comparison of Survival Outcomes of Single- and Five-Fraction Schedules of Stereotactic Body Radiation Therapy for Early-Stage Central or Peripheral NSCLC
por: Huang, Karen, et al.
Publicado: (2023)

Stereotactic body radiation therapy for reirradiation of localized adenocarcinoma of the pancreas
por: Lominska, Chris E, et al.
Publicado: (2012)

Stereotactic body radiation therapy for locally advanced pancreatic cancer
por: Jung, Jinhong, et al.
Publicado: (2019)

Cancer burden in slovenia with the time trends analysis
por: Zadnik, Vesna, et al.
Publicado: (2017)

Pretreatment SUV(max) predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy
por: Horne, Zachary D, et al.
Publicado: (2014)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prognostic Factors of Local Control, Overall Survival, and Toxicity
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2013)

Effect of Immunotherapy and Stereotactic Body Radiation Therapy Sequencing on Local Control and Survival in Patients With Spine Metastases
por: Eckstein, Jacob, et al.
Publicado: (2023)

Stereotactic Body Radiation Therapy for the Definitive Treatment of Early Stage Kidney Cancer: A Survival Comparison With Surgery, Tumor Ablation, and Observation
por: Grant, Stephen R., et al.
Publicado: (2020)

Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery
por: Kim, Mi-Sook, et al.
Publicado: (2015)

Development and external validation of a nomogram to predict overall survival following stereotactic body radiotherapy for early-stage lung cancer
por: Baker, Sarah, et al.
Publicado: (2020)

A hybrid planning strategy for stereotactic body radiation therapy of early stage non‐small‐cell lung cancer
por: Liu, Han, et al.
Publicado: (2018)

Stereotactic body radiation therapy for early-stage non–small-cell lung cancer in octogenarians and older: an alternative treatment
por: Bei, Yanping, et al.
Publicado: (2020)

Outpatient Anesthesia Facilitates Stereotactic Body Radiation Therapy for Early Stage Lung Cancer Patients With Advanced Cognitive Impairments
por: Gandhidasan, Senthilkumar, et al.
Publicado: (2019)

Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy Outcomes in a Single Institution
por: Doupnik, Nathan P, et al.
Publicado: (2022)

Stereotactic body radiation therapy in early-stage NSCLC: historical review, contemporary evidence and future implications
por: Abel, Stephen, et al.
Publicado: (2019)

Stereotactic body radiation therapy for the primary treatment of localized prostate cancer
por: Oliai, Caspian, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lbtqb0nea6em2remrpeca4jkd0